en.cms.net.cn
Ticker: CMSH Exchange: DELISTED

CMS is a Chinese pharmaceutical service company. They are primarily marketing, promoting and selling western and Chinese prescriptions drugs to hospitals through their proprietary sales force. They are also handling product registration for newly imported drugs on behalf of foreign companies, renewal of expired or expiring imported drug registrations, custom clearance, inspection of imported drugs and bids in collective tender processes. The company has a proprietary product in clinical development for the treatment of primary liver cancer. Therapeutic areas covered include CNS disorders (Deanxit), hepatology (GanFuLe), gastroenterology (Solofalk, Ursofalk), infectious diseases (Bioflor), urology (Cystistat), ophthalmology (Stulln Mono), cardiovascular disease (nesiritide - XinHouSu), paediatric and oncology (GanFuLe, Jinerlun). CMS was listed on AIM on 2007 and in September 2010 moved to the Hong Kong Stock Exchange (867 HK).

Latest Reports